
Category: Pharma & drug development


Catching cancer: could a new blood test rewrite oncology?

Oxytocin: the therapeutic potential of the ‘love hormone’

Crabby concoctions: Why pharma’s thirst for crustacean blood is up for debate

How a new crystallography technique may speed up drug development

How research groups are tackling the problem of biologics drug delivery

Intellectual property in the time of COVID-19

Could nanoparticles unlock the pharmaceutical benefits of turmeric?

Finding a cure for HIV with ViiV Healthcare

Peptomyc: the quest for a universal cancer treatment

What does ‘ageing’ mean when it comes to drug development?

Sky high: should US drugs prices fall in line with the rest of the world?

The rise of fake medicines in Africa

Q&A: Gavi alliance talks immunising 300 million people

Recurrent miscarriage: could this devastating condition have a simple cure?

A safer ride: the latest innovation in targeted cancer treatment

The problem of manipulated data

Why is pharma so bad at sharing clinical trial information?

Q&A: an eye on innovation with SparingVision
